This company develops ambient multimodal AI for mental and neurological health by processing vocal, visual, and speech data. Their products automate clinical documentation, enhance patient assessments, and provide objective symptom tracking for clinicians and researchers. They offer tools for clinical trials, digital health assistance, and telemedicine integration to improve care efficiency and accuracy.
Funding
$20M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for assessing mental and neurological health often rely on subjective evaluations, leading to inconsistencies and potential biases in clinical trials and patient care. Traditional assessments can be burdensome for both patients and staff, hindering frequent and comprehensive monitoring of mental health conditions.
Solution
Deliberate AI offers a multimodal AI platform that analyzes vocal, visual, and physiological data to provide objective insights into mental and neurological health. The platform uses behavioral signal processing to assess patients and staff, automate symptom tracking, and enhance the reliability of clinical trials. By integrating data from various modalities, including speech, facial expressions, and vital signs, Deliberate AI aims to improve treatment outcomes through real-time, data-driven insights during and between clinical encounters. The technology facilitates efficient clinical notes, automates remote patient monitoring, and screens patients and staff to reduce clinical burden.
Target Audience
The primary target audience includes clinicians and researchers in the mental and neurological health fields, as well as organizations conducting clinical trials and those seeking to improve patient screening and monitoring processes.
Features
- Multimodal AI analysis of vocal acoustics, speech behaviors, facial expressions, head and body motion, vital signs, and oculometry/pupillometry
- AI-COAs (AI-generated Clinical Outcome Assessments) to enhance endpoint reliability in clinical trials
- AI-EVAL for real-time comprehensive rater-monitoring to increase assessment quality
- Sophia™: a digital health assistant for patient screening, autonomous check-ins, and staff readiness assessments
- Deliberate Health™: AI Notes & Measures for automated clinical note generation and remote patient monitoring
- Telemedicine API for screening and tracking during telemedicine visits, with results available in minutes
- Multitude™ for creating Multimodal Biomarker Constellations™ for stratified trials and Companion Dx